Cargando…

Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma

OBJECTIVE: This study aimed to explore the prognostic value of preoperative red blood cell distribution width (RDW) in patients with metastatic renal cell carcinoma (mRCC). METHODS: Clinicopathological data of 230 patients with mRCC treated at the First Affiliated Hospital of Chongqing Medical Unive...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zongjie, Zhang, Fan, Ma, Xin, He, Weiyang, Gou, Xin, Zhang, Xu, Xie, Yongpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287633/
https://www.ncbi.nlm.nih.gov/pubmed/35839619
http://dx.doi.org/10.1016/j.tranon.2022.101486
_version_ 1784748294663045120
author Wei, Zongjie
Zhang, Fan
Ma, Xin
He, Weiyang
Gou, Xin
Zhang, Xu
Xie, Yongpeng
author_facet Wei, Zongjie
Zhang, Fan
Ma, Xin
He, Weiyang
Gou, Xin
Zhang, Xu
Xie, Yongpeng
author_sort Wei, Zongjie
collection PubMed
description OBJECTIVE: This study aimed to explore the prognostic value of preoperative red blood cell distribution width (RDW) in patients with metastatic renal cell carcinoma (mRCC). METHODS: Clinicopathological data of 230 patients with mRCC treated at the First Affiliated Hospital of Chongqing Medical University and the Chinese PLA General Hospital from January 2008 to December 2018 were retrospectively analyzed. Patients were stratified according to the optimal cut-off value of RDW calculated using X-tile software. The prognostic value of RDW was analyzed using the Kaplan-Meier curve with log-rank test and univariate and multivariate Cox proportional hazards models. RESULTS: A total of 230 patients were included. The optimal cut-off value of RDW obtained using X-tile software was 13.1%. The median Progression-free survival (PFS) and Overall survival (OS) of all populations were 12.06 months (IQR: 4.73–36.9) and 32.20 months (IQR: 13.73–69.46), respectively. Kaplan–Meier curves showed that patients with high RDW had worse PFS and OS than those with low RDW (median PFS of 9.7 months vs. 17.9 months, P = 0.002, and median OS of 27.8 months vs. 45.1 months, P = 0.012, respectively). Multivariate analysis showed that RDW was an independent risk factor for PFS (HR: 1.505; 95% CI: 1.111–2.037; P = 0.008) and OS (HR: 1.626; 95% CI: 1.164–2.272; P = 0.004) in mRCC after cytoreductive nephrectomy. CONCLUSION: Preoperative RDW was independently associated with PFS and OS in patients with mRCC and may be a potential predictor of survival outcomes in mRCC.
format Online
Article
Text
id pubmed-9287633
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-92876332022-07-25 Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma Wei, Zongjie Zhang, Fan Ma, Xin He, Weiyang Gou, Xin Zhang, Xu Xie, Yongpeng Transl Oncol Original Research OBJECTIVE: This study aimed to explore the prognostic value of preoperative red blood cell distribution width (RDW) in patients with metastatic renal cell carcinoma (mRCC). METHODS: Clinicopathological data of 230 patients with mRCC treated at the First Affiliated Hospital of Chongqing Medical University and the Chinese PLA General Hospital from January 2008 to December 2018 were retrospectively analyzed. Patients were stratified according to the optimal cut-off value of RDW calculated using X-tile software. The prognostic value of RDW was analyzed using the Kaplan-Meier curve with log-rank test and univariate and multivariate Cox proportional hazards models. RESULTS: A total of 230 patients were included. The optimal cut-off value of RDW obtained using X-tile software was 13.1%. The median Progression-free survival (PFS) and Overall survival (OS) of all populations were 12.06 months (IQR: 4.73–36.9) and 32.20 months (IQR: 13.73–69.46), respectively. Kaplan–Meier curves showed that patients with high RDW had worse PFS and OS than those with low RDW (median PFS of 9.7 months vs. 17.9 months, P = 0.002, and median OS of 27.8 months vs. 45.1 months, P = 0.012, respectively). Multivariate analysis showed that RDW was an independent risk factor for PFS (HR: 1.505; 95% CI: 1.111–2.037; P = 0.008) and OS (HR: 1.626; 95% CI: 1.164–2.272; P = 0.004) in mRCC after cytoreductive nephrectomy. CONCLUSION: Preoperative RDW was independently associated with PFS and OS in patients with mRCC and may be a potential predictor of survival outcomes in mRCC. Neoplasia Press 2022-07-12 /pmc/articles/PMC9287633/ /pubmed/35839619 http://dx.doi.org/10.1016/j.tranon.2022.101486 Text en © 2022 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Wei, Zongjie
Zhang, Fan
Ma, Xin
He, Weiyang
Gou, Xin
Zhang, Xu
Xie, Yongpeng
Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma
title Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma
title_full Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma
title_fullStr Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma
title_full_unstemmed Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma
title_short Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma
title_sort preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287633/
https://www.ncbi.nlm.nih.gov/pubmed/35839619
http://dx.doi.org/10.1016/j.tranon.2022.101486
work_keys_str_mv AT weizongjie preoperativeredbloodcelldistributionwidthasanindependentprognosticfactorinmetastaticrenalcellcarcinoma
AT zhangfan preoperativeredbloodcelldistributionwidthasanindependentprognosticfactorinmetastaticrenalcellcarcinoma
AT maxin preoperativeredbloodcelldistributionwidthasanindependentprognosticfactorinmetastaticrenalcellcarcinoma
AT heweiyang preoperativeredbloodcelldistributionwidthasanindependentprognosticfactorinmetastaticrenalcellcarcinoma
AT gouxin preoperativeredbloodcelldistributionwidthasanindependentprognosticfactorinmetastaticrenalcellcarcinoma
AT zhangxu preoperativeredbloodcelldistributionwidthasanindependentprognosticfactorinmetastaticrenalcellcarcinoma
AT xieyongpeng preoperativeredbloodcelldistributionwidthasanindependentprognosticfactorinmetastaticrenalcellcarcinoma